Omada Health’s (OMDA) “Buy” Rating Reiterated at BTIG Research

BTIG Research reissued their buy rating on shares of Omada Health (NASDAQ:OMDA) in a research report report published on Friday morning,Benzinga reports. BTIG Research currently has a $35.00 price objective on the stock.

Other analysts have also issued reports about the stock. Citigroup reissued an “outperform” rating on shares of Omada Health in a research report on Friday, August 14th. Robert W. Baird boosted their price objective on shares of Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 12th. Needham & Company LLC reissued a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday. JPMorgan Chase & Co. raised their target price on shares of Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $26.67.

Omada Health Stock Performance

Shares of NASDAQ:OMDA opened at $19.66 on Friday. The company has a market capitalization of $1.20 billion, a PE ratio of 393.20 and a beta of 1.86. Omada Health has a 12-month low of $10.28 and a 12-month high of $26.92. The business’s fifty day simple moving average is $22.63 and its 200-day simple moving average is $17.97.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The company had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Research analysts predict that Omada Health will post 0.09 EPS for the current year.

Insider Activity

In other Omada Health news, CEO Sean P. Duffy sold 25,886 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total transaction of $587,094.48. Following the sale, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. The trade was a 5.91% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Steven L. Cook sold 33,000 shares of the company’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $19.89, for a total transaction of $656,370.00. Following the transaction, the chief financial officer owned 133,359 shares in the company, valued at $2,652,510.51. The trade was a 19.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 259,767 shares of company stock worth $5,605,349. Corporate insiders own 6.38% of the company’s stock.

Institutional Investors Weigh In On Omada Health

A number of large investors have recently made changes to their positions in OMDA. Perceptive Advisors LLC acquired a new position in shares of Omada Health in the 2nd quarter valued at $44,402,000. Millennium Management LLC lifted its position in Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after acquiring an additional 2,096,705 shares during the period. BlackRock Inc. purchased a new stake in Omada Health during the 2nd quarter valued at about $48,775,000. Loomis Sayles & Co. L P grew its stake in Omada Health by 23.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock valued at $29,283,000 after purchasing an additional 346,588 shares during the last quarter. Finally, Jefferies Financial Group Inc. acquired a new position in shares of Omada Health in the fourth quarter valued at about $16,948,000.

Key Stories Impacting Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Analyst support remains strong: BTIG Research reaffirmed its “buy” rating and set a $35 price target, while Needham & Company also maintained a “buy” rating with a $28 target. These targets imply significant potential upside and reinforce confidence in Omada’s growth outlook.
• Positive Sentiment: Investor Day could provide new growth targets: Omada held its inaugural Investor Day and planned to present updated long-term financial targets. More ambitious revenue, profitability, or membership goals could improve investor confidence if management’s outlook exceeds current expectations. Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
• Neutral Sentiment: Investor Day transcript available: The transcript may offer additional detail on Omada’s strategy and financial targets, but the supplied report does not identify specific changes that would immediately alter earnings expectations. Omada Health Analyst/Investor Day Transcript
• Negative Sentiment: Chief accounting officer sold shares: CAO Craig Gracey sold 644 shares for approximately $14,000, reducing his direct ownership by 4.28%. The relatively small transaction is not necessarily a sign of deteriorating fundamentals, but insider selling can create short-term negative sentiment. SEC Insider Transaction Filing

Omada Health Company Profile

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.